Resistin is a predictor of asthma risk and resistin:adiponectin ratio is a negative predictor of lung function in asthma

Clinical and Experimental Allergy

Volumn 46, Issue 8, 2016, Pages 1056-1065

  Ballantyne, D ^a,b   Scott, H ^a   MacDonald Wicks, L ^b   Gibson, P G ^a,c   Wood, L G ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c JOHN HUNTER HOSPITAL   (Australia)

Author keywords

adipokines; adiponectin; asthma; obesity

Indexed keywords

ADIPONECTIN; RESISTIN;

ADULT; ARTICLE; ASTHMA; BLOOD CELL COUNT; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE SEVERITY; EXPIRATORY RESERVE VOLUME; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; LUNG FUNCTION; MALE; MEDICAL HISTORY; MIDDLE AGED; OBESITY; OBSERVATIONAL STUDY; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; RESIDUAL VOLUME; RESISTIN ADIPONECTIN RATIO; RESPIRATORY TRACT ALLERGY; RISK FACTOR; SEVERE PERSISTENT ASTHMA; SPIROMETRY; TOTAL LUNG CAPACITY; WEIGHT REDUCTION;

EID: 84979601618     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12742     Document Type: Article

References (49)

1. Beckett WS, Jacobs DR Jr, Yu X, Iribarren C, Williams OD. Asthma is associated with weight gain in females but not males, independent of physical activity. Am J Respir Crit Care Med 2001; 164:2045–50.
2. Camargo CA Jr, Weiss ST, Zhang S, Willett WC, Speizer FE. Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med 1999; 159:2582–8.
3. Guerra S, Sherrill DL, Bobaldilla A, Martinez FD, Barbee RA. The relation of body mass index to asthma, chronic bronchitis, and emphysema. Chest 2002; 122:1256–63.
4. Beuther DA, Sutherland ER. Overweight, obesity and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007; 175:661–6.
5. Wood LG, Gibson PG. Adiponectin: the link between obesity and asthma in women? Am J Respir Crit Care Med 2012; 186:1–2.
6. Dixon AE, Shade DM, Cohen RI et al. Effect of obesity on clinical presentation and response to treatment in asthma. J Asthma 2006; 43:553–8.
7. Mosen DM, Schatz M, Magid DJ, Camargo CA Jr. The relationship between obesity and asthma severity in the National Asthma Survey. J Allergy Clin Immunol 2008; 122:507–11.
8. Taylor B, Mannino D, Brown C, Crocker D, Twum-Baah N, Holguin F. Body mass index and asthma severity and control in adults. Thorax 2008; 63:14–20.
9. Vortmann M, Eisner MD. BMI and health status among adults with asthma. Obesity 2008; 16:146–52.
10. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001; 43:553–8.
11. Simpson JL, Scott RJ, Boyle MJ et al. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006; 11:54–61.
12. Scott HA, Gibson PG, Garg ML, Wood LG. Airway inflammation is augmented by obesity and fatty acids in asthma. Eur Respir J 2011; 38:594–602.
13. Wood LG, Baines KJ, Fu J, Scott HA, Gibson PG. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest 2012; 142:86–93.
14. Lugogo NL, Kraft M, Dixon AE. Does obesity produce a distinct asthma phenotype? J Appl Physiol 2010; 108:729–34.
15. Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun 2005; 334:1092–101.
16. Bruun JM, Lihn AS, Verdich C et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003; 285:E527–33.
17. Hirai H, Satoh H, Kudoh A, Watanabe T. Interaction between resistin and adiponectin in the proliferation of rat vascular smooth muscle cells. Mol Cell Endocrinol 2013; 366:108–16.
18. Sood A, Shore SA. Adiponectin, leptin, and resistin in asthma: basic mechanisms through population studies. J Allergy (Cairo) 2013; 2013:785835.
19. Scott HA, Gibson PG, Garg ML et al. Dietary restriction and exercise improve airway inflammation and clinical outcomes in overweight and obese asthma: a randomised trial. Clin Exp Allergy 2012; 43:36–49.
20. Aaron SD, Fergusson D, Dent R, Chen Y, Vandemheen KL, Dales RE. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest 2004; 125:2046–52.
21. Dixon J, Chapman L, O'Brien P. Marked improvement in asthma after lap-band surgery for morbid obesity. Obes Surg 1999; 9:385–9.
22. Eneli I, Skybo T, Camargo JC. Weight loss and asthma: a systematic review. Thorax 2008; 63:671–6.
23. Stenius-Aarniala B, Poussa T, Kvarnström J, Grönlund E-L, Ylikahrim M, Mustajoki P. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 2000; 320:827–32.
24. Masoli M, Fabian D, Holt S, Beasley R, Global initiative for asthma (GINA) program. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy 2004; 59:469–78.
25. Juniper E, O'Byrne P, Guyatt G, Ferrie P, King D. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14:902–7.
26. Juniper E, Guyatt G, Ferrie P, Griffith L. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147:832–8.
27. Miller M, Hankinson J, Brusasco V et al. Standardisation of spirometry. Eur Respir J 2005; 26:319–38.
28. Wanger J, Clausen J, Coates A et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26:511–22.
29. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159:179–87.
30. Larochelle J, Freiler J, Dice J, Hagan L. Plasma resistin levels in asthmatics as a marker of disease state. J Asthma 2007; 44:509–13.
31. Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 2002; 530:158–62.
32. Mojiminiyi OA, Abdella NA. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus. Scand J Clin Lab Invest 2007; 67:215–25.
33. Mishra A, Wang M, Schlotman J et al. Resistin-like molecule-beta is an allergen-induced cytokine with inflammatory and remodeling activity in the murine lung. Am J Physiol Lung Cell Mol Physiol 2007; 293:L305–13.
34. Al Mutairi SS, Mojiminiyi OA, Shihab-Eldeen A, Al Rammah T, Abdella N. Putative roles of circulating resistin in patients with asthma COPD and cigarette smokers. Dis Markers 2011; 31:1–7.
35. Kim KW, Shin YH, Lee KE, Kim ES, Sohn MH, Kim K-E. Relationship between adipokines and manifestations of childhood asthma. Pediatr Allergy Immunol 2008; 19:535–40.
36. Fang C, Meng Q, Wu H et al. Resistin-like molecule-beta is a human airway remodelling mediator. Eur Respir J 2012; 39:458–66.
37. Grainge C, Dulay V, Ward J et al. Resistin-like molecule-β is induced following bronchoconstriction of asthmatic airways. Respirology 2012; 17:1094–100.
38. Niimi A, Matsumoto H, Amitani R et al. Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices. Am J Respir Crit Care Med 2000; 1:1518–23.
39. Kobayashi T, Hashimoto S, Imai K et al. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma. Clin Exp Immunol 1994; 96:110–5.
40. Yokoyama A, Kohno N, Fujino S et al. Circulating interleukin-6 levels in patients with bronchial asthma. Am J Respir Crit Care Med 1995; 151:1354–8.
41. Olafsdottir IS, Gislason T, Thjodleifsson B et al. C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax 2005; 60:451–4.
42. Takemura M, Matsumoto H, Niimi A et al. High sensitivity C-reactive protein in asthma. Eur Respir J 2006; 27:908–12.
43. Mancuso P, Huffnagle G, Olszewski M, Phipps J, Peters-Golden M. Leptin corrects host defense defects after acute starvation in murine pneumococcal pneumonia. Am J Respir Crit Care Med 2006; 173:212–8.
44. Shore S, Rivera-Sanchez Y, Schwartzman I, Johnston R. Responses to ozone are increased in obese mice. J Appl Physiol 2003; 95:938–45.
45. Shore S, Schwartzman I, Mellema M, Flynt L, Imrich A, Johnston R. Effect of leptin on allergic airway responses in mice. J Allergy Clin Immunol 2005; 115:103–9.
46. Pajvani UB, Du X, Combs TP et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 2003; 278:9073–85.
47. Bottner A, Kratzsch J, Muller G et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 2004; 89:4053–61.
48. Sood A, Dominic E, Qualls C et al. Serum adiponectin is associated with adverse outcomes of asthma in men but not in women. Front Pharmacol 2011; 2:55.
49. Da Silva P, de Mello M, Cheik N et al. Reduction in the leptin concentration as a predictor of improvement in lung function in obese adolescents. Obesity Facts 2012; 5:806–20.